Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
- PMID: 21436444
- DOI: 10.1126/science.1203486
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
Abstract
Understanding how the immune system affects cancer development and progression has been one of the most challenging questions in immunology. Research over the past two decades has helped explain why the answer to this question has evaded us for so long. We now appreciate that the immune system plays a dual role in cancer: It can not only suppress tumor growth by destroying cancer cells or inhibiting their outgrowth but also promote tumor progression either by selecting for tumor cells that are more fit to survive in an immunocompetent host or by establishing conditions within the tumor microenvironment that facilitate tumor outgrowth. Here, we discuss a unifying conceptual framework called "cancer immunoediting," which integrates the immune system's dual host-protective and tumor-promoting roles.
Similar articles
-
Cancer immunoediting: from immunosurveillance to tumor escape.Nat Immunol. 2002 Nov;3(11):991-8. doi: 10.1038/ni1102-991. Nat Immunol. 2002. PMID: 12407406 Review.
-
[The immune system - how does anti-tumor immunity arise ?].Oncol Res Treat. 2014;37 Suppl 4:2-5. doi: 10.1159/000366431. Epub 2014 Sep 30. Oncol Res Treat. 2014. PMID: 25301189 German. No abstract available.
-
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.Ann N Y Acad Sci. 2013 May;1284(1):1-5. doi: 10.1111/nyas.12105. Ann N Y Acad Sci. 2013. PMID: 23651186 Free PMC article.
-
Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?Eur J Med Res. 2001 Aug 27;6(8):323-32. Eur J Med Res. 2001. PMID: 11549514 Review.
-
The immune system--is it relevant to cancer development, progression and treatment?Clin Oncol (R Coll Radiol). 2008 Mar;20(2):101-12. doi: 10.1016/j.clon.2007.10.011. Epub 2007 Nov 26. Clin Oncol (R Coll Radiol). 2008. PMID: 18037277 Review.
Cited by
-
Combining radiotherapy and cancer immunotherapy: a paradigm shift.J Natl Cancer Inst. 2013 Feb 20;105(4):256-65. doi: 10.1093/jnci/djs629. Epub 2013 Jan 4. J Natl Cancer Inst. 2013. PMID: 23291374 Free PMC article. Review.
-
Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.Nat Rev Neurosci. 2013 Apr;14(4):293-304. doi: 10.1038/nrn3464. Nat Rev Neurosci. 2013. PMID: 23511909 Review.
-
Biomarkers for glioma immunotherapy: the next generation.J Neurooncol. 2015 Jul;123(3):359-72. doi: 10.1007/s11060-015-1746-9. Epub 2015 Feb 28. J Neurooncol. 2015. PMID: 25724916 Free PMC article. Review.
-
Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin.Cancer Cell. 2012 Oct 16;22(4):494-505. doi: 10.1016/j.ccr.2012.08.017. Cancer Cell. 2012. PMID: 23079659 Free PMC article.
-
Dawn of Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.Adv Cell Gene Ther. 2018 Nov;1(3):e23. doi: 10.1002/acg2.23. Epub 2018 Oct 7. Adv Cell Gene Ther. 2018. PMID: 33043278 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous